Evidence method
Level · gp.fundamentals.debt_to_revenue
8946.80% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
HUMA · Jun 30, 2026
Humacyte, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-26-347022General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
25.62% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-5433.74% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
34.88% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
1720.44% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
-203.20% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-6649.26% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4468.97% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
642.36% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History6 statesHistory building
Period transition
What moved in the state?
- Previous
- 7246.67%
- Current
- 8946.80%
- Delta
- 1700.13%
- Previous
- 35.35%
- Current
- 25.62%
- Delta
- -9.74%
- Previous
- -5071.52%
- Current
- -5433.74%
- Delta
- -362.23%
- Previous
- -4.26%
- Current
- 34.88%
- Delta
- 39.14%
- Previous
- 2004.04%
- Current
- 1720.44%
- Delta
- -283.60%
- Previous
- -311.72%
- Current
- -203.20%
- Delta
- 108.52%
- Previous
- -5845.45%
- Current
- -6649.26%
- Delta
- -803.81%
- Previous
- 3931.72%
- Current
- 4468.97%
- Delta
- 537.25%
- Previous
- 640.40%
- Current
- 642.36%
- Delta
- 1.96%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Biological Products, (No Diagnostic Substances) peers →Derived From · HUMA Company Quality Vector →Has State · Humacyte, Inc. →Transitioned To · HUMA Fundamental State →Transitioned To · HUMA BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · HUMA CAPEX_INTENSITY_DECREASED →Transitioned To · HUMA CASH_GENERATION_DECREASED →Transitioned To · HUMA GROWTH_INCREASED →Transitioned To · HUMA INVENTORY_PRESSURE_DECREASED →Transitioned To · HUMA MARGIN_INCREASED →Transitioned To · HUMA PROFITABILITY_DECREASED →Transitioned To · HUMA R_AND_D_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.